SLC9A9 and central nervous system cancer: Statistical analysis (ANOVA) of NHE9 expression in 24 immunohistochemistry slides revealed significant variability between normal, low-grade glioma (LGG), and high-grade glioma (HGG) samples (P = 0.0185) as shown by the representative images in Fig. 8(B).